114 related articles for article (PubMed ID: 8780035)
41. Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity.
May PC; Boggs LN; Fuson KS
J Neurochem; 1993 Dec; 61(6):2330-3. PubMed ID: 8245987
[TBL] [Abstract][Full Text] [Related]
42. Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid beta(25-35) peptide as analyzed by single alanine substitution.
Sato K; Wakamiya A; Maeda T; Noguchi K; Takashima A; Imahori K
J Biochem; 1995 Dec; 118(6):1108-11. PubMed ID: 8720122
[TBL] [Abstract][Full Text] [Related]
43. Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals.
Ueda K; Shinohara S; Yagami T; Asakura K; Kawasaki K
J Neurochem; 1997 Jan; 68(1):265-71. PubMed ID: 8978734
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of β-amyloid peptide self-assembly and cytotoxicity by poly(LVFF-co-β-amino ester).
Xie H; Qiao Z; Wang H; Duan H; Yang Y; Wang C
J Pept Sci; 2015 Jul; 21(7):608-14. PubMed ID: 25931322
[TBL] [Abstract][Full Text] [Related]
45. 1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence.
Lee JP; Stimson ER; Ghilardi JR; Mantyh PW; Lu YA; Felix AM; Llanos W; Behbin A; Cummings M; Van Criekinge M
Biochemistry; 1995 Apr; 34(15):5191-200. PubMed ID: 7711039
[TBL] [Abstract][Full Text] [Related]
46. Lysophosphatidylcholine modulates fibril formation of amyloid beta peptide.
Sheikh AM; Nagai A
FEBS J; 2011 Feb; 278(4):634-42. PubMed ID: 21205198
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of amyloid fibril formation of beta-amyloid peptides via the amphiphilic surfactants.
Wang SS; Chen YT; Chou SW
Biochim Biophys Acta; 2005 Sep; 1741(3):307-13. PubMed ID: 15994066
[TBL] [Abstract][Full Text] [Related]
48. Abeta 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosis.
Wei W; Norton DD; Wang X; Kusiak JW
Brain; 2002 Sep; 125(Pt 9):2036-43. PubMed ID: 12183349
[TBL] [Abstract][Full Text] [Related]
49. The influence of the carboxyl terminus of the Alzheimer Abeta peptide on its conformation, aggregation, and neurotoxic properties.
Soreghan B; Pike C; Kayed R; Tian W; Milton S; Cotman C; Glabe CG
Neuromolecular Med; 2002; 1(1):81-94. PubMed ID: 12025818
[TBL] [Abstract][Full Text] [Related]
50. The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology.
Seilheimer B; Bohrmann B; Bondolfi L; Müller F; Stüber D; Döbeli H
J Struct Biol; 1997 Jun; 119(1):59-71. PubMed ID: 9216088
[TBL] [Abstract][Full Text] [Related]
51. Free radicals in the neurotoxic actions of beta-amyloid.
Richardson JS; Zhou Y; Kumar U
Ann N Y Acad Sci; 1996 Jan; 777():362-7. PubMed ID: 8624113
[TBL] [Abstract][Full Text] [Related]
52. Neurotoxicity and oxidative stress in D1M-substituted Alzheimer's A beta(1-42): relevance to N-terminal methionine chemistry in small model peptides.
Boyd-Kimball D; Sultana R; Mohmmad-Abdul H; Butterfield DA
Peptides; 2005 Apr; 26(4):665-73. PubMed ID: 15752582
[TBL] [Abstract][Full Text] [Related]
53. Prevention of amyloid-β fibril formation using antibodies against the C-terminal region of amyloid-β1-40 and amyloid-β1-42.
Montañés M; Casabona D; Sarasa L; Pesini P; Sarasa M
J Alzheimers Dis; 2013; 34(1):133-7. PubMed ID: 23160008
[TBL] [Abstract][Full Text] [Related]
54. Kinetics of aggregation of synthetic beta-amyloid peptide.
Tomski SJ; Murphy RM
Arch Biochem Biophys; 1992 May; 294(2):630-8. PubMed ID: 1567217
[TBL] [Abstract][Full Text] [Related]
55. Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR.
Balbach JJ; Ishii Y; Antzutkin ON; Leapman RD; Rizzo NW; Dyda F; Reed J; Tycko R
Biochemistry; 2000 Nov; 39(45):13748-59. PubMed ID: 11076514
[TBL] [Abstract][Full Text] [Related]
56. Amyloid beta-(1-40) stimulates cyclic GMP production via release of kinins in primary cultured endothelial cells.
Wirth KJ; Fink E; Rudolphi K; Heitsch H; Deutschländer N; Wiemer G
Eur J Pharmacol; 1999 Oct; 382(1):27-33. PubMed ID: 10556501
[TBL] [Abstract][Full Text] [Related]
57. In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
Benseny-Cases N; Klementieva O; Cladera J
Subcell Biochem; 2012; 65():53-74. PubMed ID: 23224999
[TBL] [Abstract][Full Text] [Related]
58. Identification of an antiamyloidogenic substance from mulberry leaves.
Khaengkhan P; Nishikaze Y; Niidome T; Kanaori K; Tajima K; Ichida M; Harada S; Sugimoto H; Kamei K
Neuroreport; 2009 Aug; 20(13):1214-8. PubMed ID: 19617856
[TBL] [Abstract][Full Text] [Related]
59. Characterization of Bacillus subtilis glutamine synthetase by limited proteolysis.
Kimura K; Sugano S; Funae A; Nakano Y
J Biochem; 1991 Oct; 110(4):526-31. PubMed ID: 1685734
[TBL] [Abstract][Full Text] [Related]
60. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils.
Coraci IS; Husemann J; Berman JW; Hulette C; Dufour JH; Campanella GK; Luster AD; Silverstein SC; El-Khoury JB
Am J Pathol; 2002 Jan; 160(1):101-12. PubMed ID: 11786404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
